Clinical trials

  • PEMBROLIZUMAB for Locoregionally advanced penile cancer
  • OCRELIZUMAB for Progressive multiple sclerosis | Primary progressive multiple sclerosis | Secondary progressive multiple sclerosis
  • RECOMBINANT HUMAN INTERFERON GAMMA 1B for Post-aggressive immunosuppression|Immunosuppression
  • AUTOLOGOUS TUMOUR-INFILTRATING LYMPHOCYTES for Melanoma | Non-small cell lung cancer | Cervical cancer
  • Anakinra for Familial Mediterranean Fever
  • RISANKIZUMAB for Crohn's disease
  • ZANUBRUTINIB for Mantle cell lymphoma
  • JNJ-86974680 for Advanced non-small cell lung cancer
  • CENOBAMATE for Primary generalized tonic-clonic seizures
  • TSR-042 (anti-PD-1 monoclonal antibody) for Advanced solid tumors
  • TRASTUZUMAB DERUXTECAN for Gastric cancer | Gastroesophageal junction cancer | Esophageal adenocarcinoma
  • ANIFROLUMAB for Proliferative lupus nephritis